Richard Paulson - President and CEO, Director at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard Paulson - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Richard Paulson for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common 1,164,409 $1.4 M $1.20 Mar 1, 2024 Direct
Common Stock 1,150,105 $1.14 M $0.99 Jun 4, 2024 Direct

Transactions reported by Richard Paulson for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership